<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>390-ONDANSETRON.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="ONDANSETRON" rxcui="26225">
<ATC code="A04AA01" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="APOMORPHINE" rxcui="1043">
<ATC code="G04BE07" />
<ATC code="N04BC07" />
</DRUG>
</DRUG2>
<DESCRIPTION>Severe hypotension and loss of consciousness have been reported when ondansetron is administered with apomorphine</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>390-ONDANSETRON.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="ONDANSETRON" rxcui="26225">
<ATC code="A04AA01" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="SUBSTANCES THAT TEND TO INDUCE TORSADES DE POINTES" code="C01-N05" /></DRUG2>
<DESCRIPTION>Increased risk of ventricular arrhythmias, especially of torsades de pointes </DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Clinical monitoring and EKG during the administration of these medications together. </COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>390-ONDANSETRON.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="ONDANSETRON" rxcui="26225">
<ATC code="A04AA01" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="TRAMADOL" rxcui="10689">
<ATC code="N02AX02" />
<ATC code="N02AX52" />
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the intensity and of the duration of the analgesic effect of the tramadol and risk of decrease of the antiemetic effect of the ondansetron</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
</INTERACTIONS>
